- History of another primary malignancy except for: (1) Malignancy treated with curative intent with no known active disease for 5 years before the first dose of study drug and low potential risk for recurrence; (2) Adequately treated non-melanoma skin cancer or lentigo maligna without evidence of disease; (3) Adequately treated carcinoma in situ without evidence of disease